Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation

Eukaryotic Cell

Volumn 10, Issue 12, 2011, Pages 1660-1669

  Nett, Jeniel E ^a,b   Sanchez, Hiram ^a   Cain, Michael T ^a   Ross, Kelly M ^a   Andes, David R ^a  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BETA GLUCAN; FLUCONAZOLE; FUNGAL PROTEIN; GLUCAN SYNTHASE; GLUCOSYLTRANSFERASE; PROTEIN KINASE C;

ANIMAL; ANTIFUNGAL RESISTANCE; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; CATHETER; CELL WALL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PHYSIOLOGY; RAT; ULTRASTRUCTURE; VIRULENCE;

ANIMALS; ANTIFUNGAL AGENTS; BETA-GLUCANS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; CATHETERS; CELL WALL; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENE KNOCKOUT TECHNIQUES; GLUCOSYLTRANSFERASES; MICE; PROTEIN KINASE C; RATS; VIRULENCE;

EID: 82555161649     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.05126-11     Document Type: Article

References (52)

1. Al-Fattani, M. A., and L. J. Douglas. 2004. Penetration of Candida biofilms by antifungal agents. Antimicrob. Agents Chemother. 48:3291-3297.
2. Al-Fattani, M. A., and L. J. Douglas. 2006. Biofilm matrix of Candida albi-cans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol. 55:999-1008.
3. Andes, D. 2005. Use of an animal model of disseminated candidiasis in the evaluation of antifungal therapy. Methods Mol. Med. 118:111-128.
4. Andes, D., et al. 2006. Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. Antimicrob. Agents Chemother. 50:2374-2383.
5. Andes, D., et al. 2004. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect. Immun. 72:6023-6031.
6. Baillie, G. S., and L. J. Douglas. 1998. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob. Agents Che-mother. 42:1900-1905.
7. Baillie, G. S., and L. J. Douglas. 1999. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol. 310:644-656.
8. Baillie, G. S., and L. J. Douglas. 2000. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 46:397-403.
9. Blankenship, J. R., S. Fanning, J. J. Hamaker, and A. P. Mitchell. 2010. An extensive circuitry for cell wall regulation in Candida albicans. PLoS Pathog. 6:e1000752.
10. Bruno, V. M., et al. 2006. Control of the C. albicans cell wall damage response by transcriptional regulator Cas5. PLoS Pathog. 2:e21.
11. Chandra, J., et al. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 5385-5394.
12. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
13. Dijkgraaf, G. J., J. L. Brown, and H. Bussey. 1996. The KNH1 gene of Saccharomyces cerevisiae is a functional homolog of KRE9. Yeast 12:683-692.
14. Douglas, L. J. 2002. Medical importance of biofilms in Candida infections. Rev. Iberoam. Micol. 19:139-143.
15. Fuchs, B. B., and E. Mylonakis. 2009. Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways. Eukaryot. Cell 8:1616-1625.
16. Hong, Z., et al. 1994. Cloning and characterization of KNR4, a yeast gene involved in (1,3)-beta-glucan synthesis. Mol. Cell. Biol. 14:1017-1025.
17. Hong, Z., P. Mann, K. J. Shaw, and B. Didomenico. 1994. Analysis of beta-glucans and chitin in a Saccharomyces cerevisiae cell wall mutant using high-performance liquid chromatography. Yeast 10:1083-1092.
18. Khot, P. D., P. A. Suci, R. L. Miller, R. D. Nelson, and B. J. Tyler. 2006. A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergos- terol and beta-1,6-glucan pathway genes. Antimicrob. Agents Chemother. 50:3708-3716.
19. Kojic, E. M., and R. O. Darouiche. 2004. Candida infections of medical devices. Clin. Microbiol. Rev. 17:255-267.
20. Kumamoto, C. A. 2005. A contact-activated kinase signals Candida albicans invasive growth and biofilm development. Proc. Natl. Acad. Sci. U. S. A. 102:5576-5581.
21. Kumamoto, C. A., and M. D. Vinces. 2005. Alternative Candida albicans lifestyles: growth on surfaces. Annu. Rev. Microbiol. 59:113-133.
22. LaFleur, M. D., C. A. Kumamoto, and K. Lewis. 2006. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50:3839-3846.
23. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) method. Methods 25:402-408.
24. Mah, T. F., et al. 2003. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306-310.
25. Mansfield, B. E., et al. 2010. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi. PLoS Pathog. 6:e1001126.
26. Martin-Yken, H., A. Dagkessamanskaia, F. Basmaji, A. Lagorce, and J. Francois. 2003. The interaction of Slt2 MAP kinase with Knr4 is necessary for signalling through the cell wall integrity pathway in Saccharomyces cerevi- siae. Mol. Microbiol. 49:23-35.
27. McCourtie, J., and L. J. Douglas. 1985. Extracellular polymer of Candida biofilm matrix and cell wall integrity 1669 albicans: isolation, analysis and role in adhesion. J. Gen. Microbiol. 131:495-503.
28. Mukherjee, P. K., J. Chandra, D. M. Kuhn, and M. A. Ghannoum. 2003. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect. Immun. 71:4333-4340.
29. NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing. Document M27-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
30. Nett, J., L. Lincoln, K. Marchillo, and D. Andes. 2007. Beta-1,3 glucan as a test for central venous catheter biofilm infection. J. Infect. Dis. 195:1705-1712.
31. Nett, J., et al. 2007. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother. 51:510-520.
32. Nett, J. E., K. Crawford, K. Marchillo, and D. R. Andes. 2010. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob. Agents Chemother. 54:3505-3508.
33. Nett, J. E., K. M. Guite, A. Ringeisen, K. A. Holoyda, and D. R. Andes. 2008. Reduced biocide susceptibility in Candida albicans biofilms. Antimicrob. Agents Chemother. 52:3411-3413.
34. Nett, J. E., H. Sanchez, M. T. Cain, and D. R. Andes. 2010. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J. Infect. Dis. 202:171-175.
35. Nobile, C. J., et al. 2006. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog. 2:e63.
36. Nobile, C. J., and A. P. Mitchell. 2009. Large-scale gene disruption using the UAU1 cassette. Methods Mol. Biol. 499:175-194.
37. Nobile, C. J., et al. 2008. Complementary adhesin function in C. albicans biofilm formation. Curr. Biol. 18:1017-1024.
38. Nobile, C. J., et al. 2008. Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions. Cell. Microbiol. 10:2180-2196.
39. Noble, S. M., and A. D. Johnson. 2005. Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albi cans. Eukaryot. Cell 4:298-309.
40. Norice, C. T., F. J. Smith, Jr., N. Solis, S. G. Filler, and A. P. Mitchell. 2007. Requirement for Candida albicans Sun41 in biofilm formation and virulence. Eukaryot. Cell 6:2046-2055.
41. Odabasi, Z., et al. 2004. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39:199-205.
42. Pappas, P. G., et al. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
43. Ramage, G., S. Bachmann, T. F. Patterson, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Investigation of multidrug efflux pumps in relation to flucona-zole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 49:973-980.
44. Ramage, G., and J. L. Lopez-Ribot. 2005. Techniques for antifungal suscep-tibility testing of Candida albicans biofilms. Methods Mol. Med. 118:71-79.
45. Ramage, G., K. Vande Walle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
46. Reinoso-Martin, C., C. Schuller, M. Schuetzer-Muehlbauer, and K. Kuchler. 2003. The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot. Cell 2:1200-1210.
47. Samaranayake, Y. H., J. Ye, J. Y. Yau, B. P. Cheung, and L. P. Samaranay-ake. 2005. In vitro method to study antifungal perfusion in Candida biofilms. J. Clin. Microbiol. 43:818-825.
48. Sampaio, P., et al. 2009. Increased number of glutamine repeats in the C-terminal of Candida albicans Rlm1p enhances the resistance to stress agents. Antonie Van Leeuwenhoek 96:395-404.
49. Sanglard, D., et al. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
50. Uppuluri, P., J. Nett, J. Heitman, and D. Andes. 2008. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob. Agents Chemother. 52:1127-1132.
51. Vediyappan, G., T. Rossignol, and C. d'Enfert. 2010. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob. Agents Chemother. 54:2096-2111.
52. Wilson, R. B., D. Davis, and A. P. Mitchell. 1999. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J. Bacteriol. 181:1868-1874.